Summary

Japan Palliative Care Market Research Report By Type (Hospital Inpatient Care, Hospice Inpatient Care, Nursing Homes, Residential Facility Care, Homecare, Private Residence Care), By End-User (Long Term Care Centers & Rehabilitation Centers, Hospitals & Clinics, Palliative Care Centers, Home Care Settings) and By Application (Cardiac Disease, Congestive Heart Failure, Cancer, Chronic Obstructive Pulmonary Disease (COPD), Kidney Failure, Alzheimer’s Disease, Parkinson’s Disease, Amyotrophic Lateral Sclerosis (ALS)) -Forecast to 2035

Market Summary:
As per Market Research Future analysis, the Japan palliative care market size was estimated at 164.1 USD Million in 2024. The Japan palliative care market is projected to grow from 176.24 USD Million in 2025 to 360.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 7% during the forecast period 2025 - 2035

Market Drivers:
The aging population in Japan is a critical driver for the palliative care market. As of 2025, approximately 28% of the population is aged 65 and older, leading to an increased prevalence of chronic illnesses such as cancer, heart disease, and dementia. This demographic shift necessitates a robust palliative care framework to address the complex needs of elderly patients. The palliative care market is likely to expand as healthcare providers adapt to these demographic changes, ensuring that patients receive comprehensive care that focuses on quality of life. Furthermore, the government has recognized the importance of integrating palliative care into standard healthcare practices, which may further stimulate market growth. The combination of an aging population and the rising incidence of chronic conditions suggests a sustained demand for palliative care services in Japan. Cultural attitudes towards end-of-life care are gradually shifting in Japan, which may positively impact the palliative care market. Traditionally, discussions surrounding death and dying have been considered taboo; however, there is a growing recognition of the importance of quality of life in the final stages of life.

Market Segment Analysis:
Japan Palliative Care Market Segment Insights Palliative Care Market Type Insights The Japan Palliative Care Market is multifaceted and comprises various types that cater to the diverse needs of patients with serious illnesses. Among these types, Hospital Inpatient Care plays a pivotal role in providing immediate medical support and symptom management, ensuring that patients have access to healthcare professionals who are equipped to manage complex medical situations. Hospice Inpatient Care, on the other hand, is vital for terminally ill patients who require a comprehensive approach to care that emphasizes comfort and quality of life in their final days.Nursing Homes and Residential Facility Care provide ongoing support and monitored health services for individuals who require assistance in daily activities and medical needs, promoting a supportive living environment tailored for the elderly and those with chronic conditions.

Regional Analysis:
The palliative care market in Japan is experiencing notable evolution, driven by an increasing recognition of the importance of quality of life for patients with serious illnesses. This shift is largely influenced by demographic changes, particularly the aging population, which necessitates enhanced healthcare services tailored to the needs of individuals facing life-limiting conditions. As healthcare providers adapt to these changes, there is a growing emphasis on integrating palliative care into standard medical practice, ensuring that patients receive comprehensive support that addresses both physical and emotional needs. Furthermore, the Japanese government has been proactive in promoting policies that encourage the development of palliative care services, reflecting a commitment to improving patient outcomes and overall healthcare quality.

Major Players:
The following companies are key participants in the Japan Palliative Care Market, playing a crucial role in market development through technological innovation, strategic partnerships, and competitive product offerings.

ページTOPに戻る

Table of Contents

TABLE OF CONTENT
1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
EXECUTIVE SUMMARY
Market Overview
Key Findings
Market Segmentation
Competitive Landscape
Challenges and Opportunities
Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
MARKET INTRODUCTION
Definition
Scope of the study
Research Objective
Assumption
Limitations
RESEARCH METHODOLOGY
Overview
Data Mining
Secondary Research
Primary Research
Primary Interviews and Information Gathering Process
Breakdown of Primary Respondents
Forecasting Model
Market Size Estimation
Bottom-Up Approach
Top-Down Approach
Data Triangulation
Validation
3 SECTION III: QUALITATIVE ANALYSIS
MARKET DYNAMICS
Overview
Drivers
Restraints
Opportunities
MARKET FACTOR ANALYSIS
Value chain Analysis
Porter's Five Forces Analysis
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of New Entrants
Threat of Substitutes
Intensity of Rivalry
COVID-19 Impact Analysis
Market Impact Analysis
Regional Impact
Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
Japan Palliative Care Market Segmentation
Palliative Care Type Outlook (USD Billion, 2018-2032)
Hospital Inpatient Care
Hospice Inpatient Care
Nursing Homes
Residential Facility Care
Homecare
Private Residence Care
Palliative Care End-User Outlook (USD Billion, 2018-2032)
Long Term Care Centers & Rehabilitation Centers
Hospitals & Clinics
Palliative Care Centers
Home Care Settings
Japan Palliative Care Application Outlook (USD Billion, 2018-2032)
Cardiac Disease
Congestive Heart Failure
Cancer
Chronic Obstructive Pulmonary Disease (COPD)
Kidney Failure
Alzheimer’s Disease
Parkinson’s Disease
Amyotrophic Lateral Sclerosis (ALS)
Palliative Care SECTION V: COMPETITIVE ANALYSIS
Competitive Landscape
Overview
Competitive Analysis
Market share Analysis
Major Growth Strategy in the palliative care market
Competitive Benchmarking
Leading Players in Terms of Number of Developments in the palliative care market
Key developments and growth strategies
New Product Launch/Service Deployment
Merger & Acquisitions
Joint Ventures
Major Players Financial Matrix
Sales and Operating Income
Major Players R&D Expenditure. 2023
Company Profiles
Mitsubishi Tanabe Pharma Corporation
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Astellas Pharma Inc.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Takeda Pharmaceutical Company Limited
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Daiichi Sanky
Company, Limited
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Chugai Pharmaceutical Co., Ltd.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
On
Pharmaceutical Co., Ltd.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Kyowa Kirin Co., Ltd.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Eisai Co., Ltd.
Financial Overview
Products Offered
Key Developments
SWOT Analysis
Key Strategies
Appendix
References
Related Reports

COMPANIES MENTIONED
Mitsubishi Tanabe Pharma Corporation, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company, Limited, Chugai Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Eisai Co., Ltd.

ページTOPに戻る

List of Tables/Graphs

LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 JAPAN PALLIATIVE CARE MARKET ANALYSIS BY TYPE
FIGURE 3 JAPAN PALLIATIVE CARE MARKET ANALYSIS BY END-USER
FIGURE 4 JAPAN PALLIATIVE CARE MARKET ANALYSIS BY APPLICATION
FIGURE 5 KEY BUYING CRITERIA OF PALLIATIVE CARE MARKET
FIGURE 6 RESEARCH PROCESS OF MRFR
FIGURE 7 DRO ANALYSIS OF JAPAN PALLIATIVE CARE MARKET
FIGURE 8 DRIVERS IMPACT ANALYSIS: JAPAN PALLIATIVE CARE MARKET
FIGURE 9 RESTRAINTS IMPACT ANALYSIS: JAPAN PALLIATIVE CARE MARKET
FIGURE 10 SUPPLY / VALUE CHAIN: JAPAN PALLIATIVE CARE MARKET
FIGURE 11 JAPAN PALLIATIVE CARE MARKET, BY TYPE, 2024 (% SHARE)
FIGURE 12 JAPAN PALLIATIVE CARE MARKET, BY TYPE, 2024 TO 2035 (USD Million)
FIGURE 13 JAPAN PALLIATIVE CARE MARKET, BY END-USER, 2024 (% SHARE)
FIGURE 14 JAPAN PALLIATIVE CARE MARKET, BY END-USER, 2024 TO 2035 (USD Million)
FIGURE 15 JAPAN PALLIATIVE CARE MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 16 JAPAN PALLIATIVE CARE MARKET, BY APPLICATION, 2024 TO 2035 (USD Million)
FIGURE 17 BENCHMARKING OF MAJOR COMPETITORS

LIST OF TABLES
LIST OF ASSUMPTIONS
Japan PALLIATIVE CARE MARKET SIZE ESTIMATES; FORECAST
TABLE 1 BY TYPE, 2026-2035 (USD Million)
TABLE 2 BY TYPE, 2026-2035 (USD Million)
TABLE 3 BY END-USER, 2026-2035 (USD Million)
TABLE 4 BY END-USER, 2026-2035 (USD Million)
TABLE 5 BY APPLICATION, 2026-2035 (USD Million)
TABLE 6 BY APPLICATION, 2026-2035 (USD Million)
PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
ACQUISITION/PARTNERSHIP